Huntington's disease gene therapy (Medtronic)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameHuntington's disease gene therapy (Medtronic)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsHuntington Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMedtronic Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedtronic Inc
Active IndicationsN/A
Inactive IndicationsHuntington Disease

Other Information

ATC CodeN/A
Related LinksN/A